Gapping up
In reaction to strong earnings/guidance:
- SSL +13.2%, SPOT +8.2%, CTB +7.6%, ON +1.7%, WBA +1.4%, T +1.2%, DTE +0.6%, L +0.5%
M&A news:
- TIF +29.2% (LVMH (LVMUY) confirms that it has held preliminary discussions regarding a possible transaction with Tiffany)
- LPT +14.5% (to be acquired by Prologis (PLD) for approximately $12.6 bln in all-stock deal)
- CRCM +12.7% (reports of sale exploration )
Other news:
- ATNX +37.4% (highlights progress update from partner Almirall on tirbanibulin ointment for the treatment of actinic keratosis)
- BCRX +8.5% (announces results from ongoing three part Phase 1 trial of BCX9930 in complement-mediated diseases)
- TGTX +8.1% (announces that the follicular lymphoma cohort of the UNITY-NHL Phase 2b pivotal trial evaluating single agent umbralisib met the primary endpoint of overall response rate)
- AGIO +6.6% (reports Phase 1 Study of AG-270; combination arms initiated)
- OSTK +5.3% (said it continues to work and consult with regulators to ensure the dividend is implemented in compliance with applicable laws and corporate requirements)
- SIG +4.3% (in sympatthy with TIF)
- GLPG +3.3% (continued strength)
- MSFT +2.7% (awarded $10 bln DOD cloud computing contract beating out Amazon (AMZN) and Oracle (ORCL))
- AXSM +2.5% (announced results of MINDSET survey)
- IRBT +2.4% (continued strength)
- ATH +1.2% (Apollo (APO) to take 18% incremental stake in the co; will acquire 7.5 million Athene shares for cash at $46.20 per share) GM +1.1% (General Motors and UAW ratify new collective bargaining agreement ending the longest automotive strike in 50 years)
Analyst comments:
- QEP +6% (upgraded to Overweight from Neutral at Piper Jaffray)
- FSLR +2.7% (upgraded to Mkt Outperform from Mkt Perform at JMP Securities)
- ROKU +2.5% (initiated with a Buy at BofA/Merrill)
- JBLU +2.3% (upgraded to Overweight from Neutral at JP Morgan)